MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
TherapeuticsMD Cash Conversion Cycle 2011-2026 | TXMD
Annual Cash Conversion Cycle TherapeuticsMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -723 | 156 | -117 | -242 | -2.35 K | -267 | -463 | -142 | -453 | -119 | 50.9 | 113 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 156 | -2.35 K | -379 |
Quarterly Cash Conversion Cycle TherapeuticsMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 8.18 K | 8.08 K | 3.09 K | 180 | -38.7 | 23.4 | -4.32 | 131 | -211 | 4.97 | -131 | 140 | -369 | -169 | -1.19 K | 198 | -2.25 K | -3.64 K | -1.4 K | 95.8 | -251 | -257 | 101 | 91.5 | 74.2 | 93.3 | 69.9 | 49.4 | 53.6 | 57.4 | 53.1 | 46.2 | 47 | 52.4 | 62 | 53.9 K | 67.2 | 74.1 | 71.4 | 48.6 K | 53.4 | 67.6 | 40 | - | 4.52 | 4.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 53.9 K | -3.64 K | 2.53 K |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
110 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M |  Irlanda |
 |
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.05 | -2.24 % | $ 42.9 M | USA |
 |
Cronos Group
CRON
|
213 | $ 2.58 | 0.19 % | $ 1.33 B |  Canada |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.71 | -0.26 % | $ 2.08 B | Canada |
 |
Tilray
TLRY
|
169 | $ 6.89 | 2.53 % | $ 4.26 B | Canada |
 |
Harrow Health
HROW
|
18.3 | $ 37.97 | 2.35 % | $ 1.4 B | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.53 | 1.44 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
177 | $ 1.09 | 0.46 % | $ 117 M | Canada |
 |
Veru
VERU
|
6.7 | $ 2.39 | 0.42 % | $ 322 M | USA |
 |
Jupiter Wellness
JUPW
|
-206 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.43 | 1.04 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | USA |
 |
Viatris
VTRS
|
155 | $ 13.97 | 0.98 % | $ 16.8 B | USA |
 |
Evolus
EOLS
|
74.8 | $ 4.39 | 1.5 % | $ 283 M | USA |
 |
Emergent BioSolutions
EBS
|
181 | $ 8.53 | 3.52 % | $ 437 M | USA |
 |
Organogenesis Holdings
ORGO
|
64.5 | $ 2.47 | 3.57 % | $ 325 M | USA |
 |
Pacira BioSciences
PCRX
|
209 | $ 23.72 | -1.41 % | $ 1.1 B | USA |
 |
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
467 | $ 18.02 | 0.03 % | $ 115 M | USA |
 |
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
92 | $ 0.73 | -2.42 % | $ 3.15 M | USA |
 |
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 1.03 | 1.98 % | $ 51.4 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.17 | -7.66 % | $ 2.69 M | USA |
 |
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
57 | $ 0.91 | -2.76 % | $ 32.7 M | USA |
 |
China Pharma Holdings
CPHI
|
139 | $ 0.63 | -3.05 % | $ 2.7 M |  China |